tldrdailynews.com logo

FDA Introduces New Voucher and AI Initiatives to Accelerate Drug Approvals

1 min read
Source: statnews.com
FDA Introduces New Voucher and AI Initiatives to Accelerate Drug Approvals
Photo: statnews.com
TL;DR

The FDA announced a new voucher program allowing companies supporting U.S. national interests to expedite their drug review process to one or two months, raising concerns about potential misuse and the influence of political criteria in fast-tracking approvals.

Topics:businesshealthcare#drug-approval#fda#healthcare#medical-innovation#regulation#voucher-program
Share this article
  1. Does the FDA commissioner’s new voucher program open a Pandora’s box?  statnews.com
  2. FDA to offer faster drug reviews to companies promoting ‘national priorities’  AP News
  3. FDA launches new priority review voucher program for biopharmas that ‘align with national priorities’  Fierce Biotech
  4. F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’  The New York Times
  5. US FDA to shorten review time for drug developers under new voucher program  Reuters

Want the full story? Read the original reporting

Read on statnews.com